Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Semba Biosciences
Madison, Wisconsin, United Statesprweb.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Semba Biosciences developed advanced continuous chromatography systems for efficient downstream purification of biomolecules. Their technologies are used in research and biomanufacturing to improve the efficiency and scalability of protein and chemical purification. The company was acquired by Tosoh Bioscience in October 2021 to enhance Tosoh's bio-purification portfolio. No clinical results as the company does not have a therapeutic pipeline.
- Industry
- Non-Drug Biotech
02
Partnerships
Tosoh Bioscience LLC / Corporation
Beyond the preview
Go deeper on Semba Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Semba Biosciences.